Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases

Journal of Viral Hepatitis

Volumn 22, Issue 4, 2015, Pages 416-426

  Coffin, Carla S ^a,b   Osiowy, C ^c   Gao, S ^a,b,d   Nishikawa, S ^a,b   Van Der Meer, F ^a,b   Van Marle, G ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

chronic hepatitis B; clonal sequencing; genotype; lymphoid; quasispecies

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; MIDDLE AGED; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME; VIRUS RESISTANCE; ANTIVIRAL RESISTANCE; BLOOD; CLASSIFICATION; GENETICS; GENOTYPING TECHNIQUE; IMMUNE EVASION; ISOLATION AND PURIFICATION; MONONUCLEAR CELL; MUTATION; PLASMA; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; COHORT STUDIES; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE EVASION; IMMUNOASSAY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUTATION; PLASMA; POLYMERASE CHAIN REACTION; VIRAL LOAD; YOUNG ADULT;

EID: 84925607143     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12308     Document Type: Article

References (60)

1. Ganem D, Prince A,. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350 (11): 1118-1129.
2. Chisari FV, Ferrari C,. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
3. Hongthanakorn C, Chotiyaputta W, Oberhelman K, et al,. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology 2011; 53 (6): 1854-1863.
4. Norder H, Courouce AM, Coursaget P, et al,. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47 (6): 289-309.
5. Kim BK, Revill PA, Ahn SH,. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther 2011; 16 (8): 1169-1186.
6. Bartholomeusz A, Locarnini S,. Hepatitis B virus mutations associated with antiviral therapy. J Med Virol 2006; 78 (Suppl. 1): S52-S55.
7. Sheldon J, Soriano V,. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother 2008; 61 (4): 766-768.
8. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY,. Molecular evolution of hepatitis B virus over 25 years. J Virol 2006; 80 (21): 10307-10314.
9. Huang CJ, Wu CF, Lan CY, et al,. Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression. PLoS ONE 2013; 8 (7): e70169.
10. Cheng Y, Guindon S, Rodrigo A, Lim SG,. Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy. J Hepatol 2013; 58 (2): 217-224.
11. Wang HY, Chien MH, Huang HP, et al,. Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J Virol 2010; 84 (7): 3454-3463.
12. Chen L, Zheng CX, Lin MH, et al,. Distinct quasispecies characteristics and positive selection within precore/core gene in hepatitis B virus HBV associated acute-on-chronic liver failure. J Gastroenterol Hepatol 2013; 28 (6): 1040-1046.
13. Lim SG, Cheng Y, Guindon S, et al,. Viral quasi-species evolution during hepatitis Be antigen seroconversion. Gastroenterology 2007; 133 (3): 951-958.
14. Chen L, Zhang Q, Yu DM, Wan MB, Zhang XX,. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy. J Hepatol 2009; 50 (5): 895-905.
15. Liu F, Chen L, Yu DM, et al,. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy. Gut 2011; 60 (9): 1269-1277.
16. Pontisso P, Vidalino L, Quarta S, Gatta A,. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev 2008; 8 (1): 13-17.
17. Michalak TI, Mulrooney PM, Coffin CS,. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol 2004; 78 (4): 1730-1738.
18. Coffin CS, Michalak TI,. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999; 104 (2): 203-212.
19. Datta S, Panigrahi R, Biswas A, et al,. Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation. J Virol 2009; 83 (19): 9983-9992.
20. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA,. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl 2011; 17 (8): 955-962.
21. Coffin CS, Mulrooney-Cousins PM, Peters MG, et al,. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat 2011; 18 (6): 415-423.
22. Congly SE, Wong P, Al-Busafi SA, et al,. Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres. Liver Int 2013; 33 (9): 1363-1369.
23. Osiowy C, Larke B, Giles E,. Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey. J Viral Hepat 2011; 18 (4): e11-e19.
24. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H,. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69 (9): 5437-5444.
25. Datta S, Banerjee A, Chandra PK, Chakravarty R,. Selecting a genetic region for molecular analysis of hepatitis B virus transmission. J Clin Microbiol 2007; 45 (2): 687; author reply 8.
26. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S,. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28 (10): 2731-2739.
27. Zoulim F, Locarnini S,. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009; 137 (5): 1593-1608.e1-2.
28. Ghany M, Liang TJ,. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 2007; 132 (4): 1574-1585.
29. Qin B, Budeus B, Cao L, et al,. The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir. Antiviral Res 2013; 97 (2): 93-100.
30. Torresi J, Earnest-Silveira L, Civitico G, et al,. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 2002; 299 (1): 88-99.
31. Seddigh-Tonekaboni S, Waters JA, Jeffers S, et al,. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000; 60 (2): 113-121.
32. Hou J, Wang Z, Cheng J, et al,. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 2001; 34 (5): 1027-1034.
33. Pollicino T, Raffa G, Costantino L, et al,. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45 (2): 277-285.
34. Zaaijer HL, Torres P, Ontanon A, et al,. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection. J Med Virol 2008; 80 (8): 1344-1349.
35. Lada O, Benhamou Y, Poynard T, Thibault V,. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol 2006; 80 (6): 2968-2975.
36. Lee SA, Kim K, Kim H, Kim BJ,. Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases. J Hepatol 2012; 56 (1): 63-69.
37. Westhoff TH, Jochimsen F, Schmittel A, et al,. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003; 102 (5): 1930.
38. Brind A, Jiang J, Samuel D, et al,. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol 1997; 26 (2): 228-235.
39. Shao Q, Zhao X, Yao Li MD,. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection. Arch Gynecol Obstet 2013; 288 (6): 1257-1261.
40. Chakravarty R, Neogi M, Roychowdhury S, Panda CK,. Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res 2002; 90 (1-2): 133-141.
41. Cassini R, De Mitri MS, Gibellini D, et al,. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. J Viral Hepat 2013; 20 (1): 42-49.
42. Bagaglio S, Albarello L, Biswas P, Uberti-Foppa C, Fortis C, Morsica G,. Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report. J Med Case Rep 2009; 3: 110.
43. Michalak TI, Pardoe IU, Coffin CS, et al,. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29 (3): 928-938.
44. Zehender G, De Maddalena C, Bernini F, et al,. Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol 2005; 79 (14): 9145-9156.
45. van Marle G, Gill MJ, Kolodka D, McManus L, Grant T, Church DL,. Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology 2007; 4: 87.
46. van Marle G, Church DL, Nunweiler KD, Cannon K, Wainberg MA, Gill MJ,. Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection. Retrovirology 2010; 7: 74.
47. Potter SJ, Dwyer DE, Saksena NK,. Differential cellular distribution of HIV-1 drug resistance in vivo: evidence for infection of CD8 + T cells during HAART. Virology 2003; 305 (2): 339-352.
48. Blackard JT, Ma G, Sengupta S, et al,. Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. J Med Virol 2014; 86 (8): 1332-1341.
49. Peveling-Oberhag J, Herrmann E, Kronenberger B, et al,. Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs. J Viral Hepat 2013; 20 (4): 234-239.
50. Kim do Y, Chang HY, Lim SM, et al,. Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver 2013; 7 (3): 329-334.
51. Rodriguez C, Chevaliez S, Bensadoun P, Pawlotsky JM,. Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing. Hepatology 2013; 58 (3): 890-901.
52. Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL,. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B. Gastroenterology 2010; 139 (2): 491-498.
53. Oon CJ, Chen WN, Zhao Y, Teng SW, Leong AL,. Detection of hepatitis B surface antigen mutants and their integration in human hepatocellular carcinoma. Cancer Lett 1999; 136 (1): 95-99.
54. Kalinina T, Riu A, Fischer L, Will H, Sterneck M,. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology 2001; 34 (2): 385-394.
55. Hannoun C, Krogsgaard K, Horal P, Lindh M,. Interpred trial g. Genotype mixtures of hepatitis B virus in patients treated with interferon. J Infect Dis 2002; 186 (6): 752-759.
56. Toan NL, le Song H, Kremsner PG, et al,. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 2006; 43 (6): 1375-1384.
57. Chauhan R, Kazim SN, Kumar M, Bhattacharjee J, Krishnamoorthy N, Sarin SK,. Identification and characterization of genotype A and D recombinant hepatitis B virus from Indian chronic HBV isolates. World J Gastroenterol 2008; 14 (40): 6228-6236.
58. Andernach IE, Jutavijittum P, Samountry B, et al,. A high variability of mixed infections and recent recombinations of hepatitis B virus in Laos. PLoS ONE 2012; 7 (2): e30245.
59. Olinger CM, Venard V, Njayou M, et al,. Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 2006; 87 (Pt 5): 1163-1173.
60. Ramirez C, Gregori J, Buti M, et al,. A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model. Antiviral Res 2013; 98 (2): 273-283.